Description
Mopa
Description
Methyldopa is a centrally acting antihypertensive drug.
Indications
Methyldopa is primarily indicated for the treatment of hypertension (high blood pressure).
- Hypertension in Pregnancy: It is considered one of the safest and most well-studied antihypertensives for use during pregnancy.
- Patients with chronic kidney disease where other agents may not be suitable.
Mechanism of Action
Methyldopa’s therapeutic effect is due to its conversion into a false neurotransmitter that mimics the action of a natural one, leading to reduced sympathetic nervous system activity.
- Conversion to a “False” Neurotransmitter: After oral administration, methyldopa is transported into the central nervous system (brainstem) and is converted by the enzyme DOPA decarboxylase into alpha-methyldopamine, and then further converted by the enzyme dopamine beta-hydroxylase into alpha-methylnorepinephrine.
- Alpha-2 Agonism: Alpha-methylnorepinephrine then acts as a potent agonist (activator) of the presynaptic alpha-2 adrenergic receptors in the brainstem.
- Reduced Sympathetic Outflow: When these receptors are stimulated, they act as a negative feedback loop, reducing the release of the primary sympathetic neurotransmitter, norepinephrine, from nerve terminals.
This decreases the overall sympathetic nervous system outflow from the central nervous system. - Blood Pressure and Heart Rate Reduction: The reduced sympathetic stimulation to the heart and blood vessels leads to:
- Peripheral Vasodilation: Blood vessels relax and widen, reducing peripheral resistance.
- Peripheral Vasodilation: Blood vessels relax and widen, reducing peripheral resistance.
-
- Decreased Heart Rate and Cardiac Output: The heart beats more slowly, and the amount of blood it pumps per minute decreases.
The combined effect of vasodilation and reduced cardiac output results in a significant and sustained reduction in blood pressure.


Reviews
There are no reviews yet.